vVARDIS

📍 Zug, Switzerland🗓 Founded 2019👥 77 employees💰 Last funded Sep 2021
Founded in Switzerland by Dr. Haley Abivardi, DMD & Dr. Goly Abivardi, DMD, vVARDIS is the result of a combined 30 years of dental and entrepreneurial experience, 20 years of research paired with the creative vision of its founders. At the heart of vVARDIS is the breakthrough patented biomimetic peptide technology in Curodont Repair. Proven in more than 200 publications, it can arrest and reverse early caries via in-depth remineralization and regeneration of enamel, offering a non-invasive, pain-free solution for patients of all ages. Incredibly versatile, the vVARDIS peptide technology is present in all our professional and daily oral care products offering protection from tooth decay, erosion, and sensitivity. The future of oral health is here.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
Switzerland
1
United States
1
Frequently asked questions
Who invested in vVARDIS?
vVARDIS has 2 investors on record on gritt.io, including 2 early-stage backers.
When did vVARDIS last raise funding?
The most recent investment in vVARDIS recorded on gritt.io was in September 2021.
When was vVARDIS founded?
vVARDIS was founded in 2019.
What industry is vVARDIS in?
vVARDIS operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is vVARDIS based?
vVARDIS is headquartered in Zug, Switzerland.